Formulate Labs, Inc.

New Filing
CIK: 0001827318·Other·DELAWARE·Filed: Oct 7, 2020
Total Offering

$2,500,000

Amount Sold

$1,443,600

Investors

7

First Sale

Sep 22, 2020

Offering Details

Type
Equity
Exemptions
Rule 506(b)
Entity Type
Corporation
Year Incorporated
2018
Non-Accredited Investors
No

Related Persons

NameRole
Osmaan Shah
Related Person
Jason Calacanis
Related Person

Company

Formulate Labs, Inc.

101 JEFFERSON DR., SUITE 233K

MENLO PARK, CA, 94025

312-283-4854

SEC Filing

0001827318-20-000001

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free
Formulate Labs, Inc. Form D Filing — $2,500,000 | FilingFlow